NSC |
Compound |
Enrichment |
Correlation |
NSC 647117 |
Null |
0.00134664791567076 |
0.024637776 |
NSC 658103 |
Null |
0.00134664791567076 |
0.2387186 |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.00134664791567076 |
0.36610019 |
NSC 681636 |
Camptothecin Derivative |
0.00134664791567076 |
0.3468995 |
NSC 720296 |
Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-methyl)cyclohexane |
0.00134664791567076 |
0.1928692 |
NSC 724994 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.00134664791567076 |
0.47894109 |
NSC 725774 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.00134664791567076 |
0.41728349 |
NSC 631578 |
Null |
0.0013655184802855 |
0.22373845 |
NSC 694619 |
Null |
0.0013655184802855 |
0.17411164 |
NSC 106557 |
5.alpha.,25D-Spirostan-3.beta.-ol glycoside |
0.00136551848028552 |
0.2560224 |